Overview Fundamentals API Earnings EOD API Sample Code Pricing

Supported exchanges /
LSE /
0UNL.LSE

Nektar Therapeutics (0UNL LSE) stock market data APIs

$1.31 0.05(4%) as of September 18, 2024

Price chart is built with Anychart

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. The company is developing rezpegaldesleukin, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 2b clinical trial to treat atopic dermatitis and psoriasis; and NKTR-255, an IL-15 receptor agonist, which is in phase 1 clinical trial to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.

Nektar Therapeutics Financial Data Overview

Prev. Close	1.26
Open	1.31
Volume	-
High	1.31
Low	1.26
52 wk Range	0.435-1.925
Market Cap	22 118 M
P/E Ratio
Shares Outstanding	173 M
Revenue	93 157 K
EPS	-0.2507
Dividends (Yield)
Beta	0.599

Our easy-to-use no-coding solutions help you get the data effortlessly:

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

Prices start at $19.99/month

General: {

Code: '0UNL',

Type: 'Common Stock',

Name: 'Nektar Therapeutics',

Exchange: 'LSE',

CurrencyCode: 'USD',

CurrencyName: 'US Dollar',

CurrencySymbol: '$',

CountryName: 'UK',

CountryISO: 'GB',

OpenFigi: NULL,

ISIN: NULL,

CIK: NULL,

EmployerIdNumber: NULL,

FiscalYearEnd: 'December',

IPODate: NULL,

InternationalDomestic: NULL,

Sector: '',

Industry: '',

}

Nektar Therapeutics Fundamental Data is available in our Financial Data APIs

Net Revenue 93 157 K
EBITDA -128 688 000
Earnings Per Share -2.664
Income Statements
Balance Sheets
Cash flows

Fundamental data package from $59.99 See full price

Get sample
of Fundamental API Data

Get Nektar Therapeutics Earnings via APIs

Latest Release 2024-08-08
EPS/Forecast NaN

Calendar package from $19.99 See full price

Get sample
earnings calendar API

Get Nektar Therapeutics End-of-day Data via APIs

End of Day, Intraday and Live APIs
Splits
Dividends

All world package from $19.99 See full price

Get sample
of End-of-Day API Data

Robust, powerful and easy to use

Our advantages

Prices start at
$19.99

Fast+ support 24/7 via web-chat and email

Robust, powerful and reliable data

One click API for all financial data you need

Sample code for your quick start

Ready-to-go solutions

Our easy-to-use no-coding solutions help you get the data directly to MS Excel and Google Sheets. Or download the CSV (TXT) files effortlessly with tools for Windows and Linux.

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

Best price for all data API

Prices start at $19.99/month

All-In-One

$99.99/per month

100 000+ API requests per day
EOD Data - All World Extended
Splits and Dividends
Fundamental Data
Bonds Data
Options Data
1000+ currency pairs
1000+ cryptocurrency pairs

Do you have any questions?

support@eodhistoricaldata.com